Protective Immune Response Against Yersinia pestis
U.S. Army Medical Research Institute of Infectious Diseases, US Army Medical Research Insti Infec Diseases
We are currently pursuing novel vaccine strategies against Yersinia pestis (etiologic agent of plague). These will include subunit vaccines, live vaccine strategies, and passive protection studies. The ultimate goal is to identify epitopes that are protective against both bubonic and pneumonic plague. Additionally, we hope to better understand the aspects of a lasting protective immune response.
$3,000 Supplement per year of participation in DTRA CBD-supported NRC tenure at USAMRIID
Experience Supplement: Postdoctoral and Senior Associates will receive an appropriately higher stipend based on the number of years of experience past their PhD.